BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37193461)

  • 1. Generalized Vitiligo Following Radiation Therapy for a B2 Thymoma: A Case Report.
    Sirody J; Orlinsky D; Simmons-O'Brien E
    Cureus; 2023 Apr; 15(4):e37538. PubMed ID: 37193461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalized vitiligo post radiotherapy in a breast cancer patient.
    Vajrala G; Jain PK; Surana S; Fernandes DJ
    J Cancer Res Ther; 2014; 10(2):365-7. PubMed ID: 25022394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitiligo-like Depigmentation in a Patient Undergoing Treatment with Nivolumab for Advanced Renal-cell Carcinoma.
    Navarro-Fernandez I; Gonzalez-Vela C; Gomez-Fernandez C; Duran-Vian C; Reguero L; Gonzalez-Lopez M
    Acta Dermatovenerol Croat; 2021 Apr; 291(1):54-55. PubMed ID: 34477066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitiligo at the sites of irradiation in a patient with Hodgkin's disease.
    Pajonk F; Weissenberger C; Witucki G; Henke M
    Strahlenther Onkol; 2002 Mar; 178(3):159-62. PubMed ID: 11962193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of guidelines for the treatment of vitiligo. Clinical Epidemiology Unit of the Istituto Dermopatico dell'Immacolata-Istituto di Recovero e Cura a Carattere Scientifico (IDI-IRCCS) and the Archives of Dermatology.
    Njoo MD; Westerhof W; Bos JD; Bossuyt PM
    Arch Dermatol; 1999 Dec; 135(12):1514-21. PubMed ID: 10606057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of Janus kinase inhibitors and narrowband ultraviolet B combination therapy in non-segmental vitiligo.
    Yousefian F; Yadlapati S; Browning JC
    J Cosmet Dermatol; 2023 Mar; 22(3):1105-1107. PubMed ID: 36440703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case Report: Immune checkpoint inhibitor-related vitiligo-like depigmentation in non-melanoma advanced cancer: A report of three cases and a pooled analysis of individual patient data.
    Rao H; Guo Z; Wen X; Zeng X; Wu L; Huang L
    Front Oncol; 2022; 12():1099108. PubMed ID: 36713515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vitiligo: Clinical presentation and pathogenesis].
    Schild M; Meurer M
    Hautarzt; 2016 Feb; 67(2):173-86; quiz 187-9. PubMed ID: 26781864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitiligo at the site of radiotherapy for nasopharyngeal carcinoma.
    Polat M; Yalçin B; Alli N
    Am J Clin Dermatol; 2007; 8(4):247-9. PubMed ID: 17645381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The changes of gene expression profiling between segmental vitiligo, generalized vitiligo and healthy individual.
    Wang P; Li Y; Nie H; Zhang X; Shao Q; Hou X; Xu W; Hong W; Xu A
    J Dermatol Sci; 2016 Oct; 84(1):40-49. PubMed ID: 27470284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Segmental vitiligo associated with generalized vitiligo (mixed vitiligo): a retrospective case series of 19 patients.
    Ezzedine K; Gauthier Y; Léauté-Labrèze C; Marquez S; Bouchtnei S; Jouary T; Taieb A
    J Am Acad Dermatol; 2011 Nov; 65(5):965-71. PubMed ID: 21616559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological basis of melanoma-associated vitiligo-like depigmentation.
    González R; Torres-López E
    Actas Dermosifiliogr; 2014 Mar; 105(2):122-7. PubMed ID: 23146137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitiligo patients seeking depigmentation therapy: a case report and guidelines for psychological screening.
    Grau C; Silverberg NB
    Cutis; 2013 May; 91(5):248-52. PubMed ID: 23772431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraneoplastic Vitiligo Associated With Adrenocortical Carcinoma.
    Goodkin DA; Failor RA; Habra MA
    JCEM Case Rep; 2024 May; 2(5):luae070. PubMed ID: 38707658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitiligo: a review of the published work.
    Yaghoobi R; Omidian M; Bagherani N
    J Dermatol; 2011 May; 38(5):419-31. PubMed ID: 21667529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vitiligo. Diagnosis, differential diagnosis, and current patient management].
    Hartmann A
    Hautarzt; 2009 Jun; 60(6):505-14; quiz 515. PubMed ID: 19444398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant HSP70 reverses autoimmune depigmentation in vitiligo.
    Mosenson JA; Zloza A; Nieland JD; Garrett-Mayer E; Eby JM; Huelsmann EJ; Kumar P; Denman CJ; Lacek AT; Kohlhapp FJ; Alamiri A; Hughes T; Bines SD; Kaufman HL; Overbeck A; Mehrotra S; Hernandez C; Nishimura MI; Guevara-Patino JA; Le Poole IC
    Sci Transl Med; 2013 Feb; 5(174):174ra28. PubMed ID: 23447019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Report of a case of radiation-induced new-onset vitiligo with collective review of cases in the literature of radiation-related vitiligo.
    Pavithran K; Pande SB; Dinesh M
    Case Rep Med; 2013; 2013():345473. PubMed ID: 23983707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variations in nalp1 mRNA expressions in human vitiligo.
    Deo SS; Bhagat AR; Shah RN
    Indian J Dermatol; 2011 May; 56(3):266-71. PubMed ID: 21772585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consensus on the treatment of vitiligo - Brazilian Society of Dermatology.
    Dellatorre G; Antelo DAP; Bedrikow RB; Cestari TF; Follador I; Ramos DG; Silva de Castro CC
    An Bras Dermatol; 2020; 95 Suppl 1(Suppl 1):70-82. PubMed ID: 33153826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.